Showing results (51-60 of 60) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 60 results.
Science Advances|March 13, 2026
IL-7/IL-15/IL-21 cytokine-fusion scaffold generates highly functional CAR T cells enriched in long-lived T memory stem cellsErin B Cole, Sara Lamcaj, Agnes V Sydenstricker, et al.
Virus Evolution|January 13, 2025
A simple phylogenetic approach to analyze hypermutated HIV proviruses reveals insights into their dynamics and persistence during antiretroviral therapyAniqa Shahid, Bradley R Jones, Maggie C Duncan, et al.
Nature Aging|June 12, 2024
Conserved epigenetic hallmarks of T cell aging during immunity and malignancyTian Mi, Andrew G Soerens, Shanta Alli, et al.
Journal of Virology|August 4, 2019
Rapid Elimination of Broadly Neutralizing Antibodies Correlates with Treatment Failure in the Acute Phase of Simian-Human Immunodeficiency Virus InfectionYanling Wu, Jing Xue, Chunyu Wang, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 6, 2007
Availability of a diversely avid CD8+ T cell repertoire specific for the subdominant HLA-A2-restricted HIV-1 Gag p2419-27 epitopeKeri L Schaubert, David A Price, Nicole Frahm, et al.
European Journal of Immunology|May 1, 2010
Generation of robust CD8+ T-cell responses against subdominant epitopes in conserved regions of HIV-1 by repertoire mining with mimotopesKeri L Schaubert, David A Price, Janelle R Salkowitz, et al.
Research Square|August 30, 2023
The replication-competent HIV reservoir is a genetically restricted, younger subset of the overall pool of HIV proviruses persisting during therapy, which is highly genetically stable over timeAniqa Shahid, Signe MacLennan, Bradley R Jones, et al.
Journal of Virology|January 12, 2024
The replication-competent HIV reservoir is a genetically restricted, younger subset of the overall pool of HIV proviruses persisting during therapy, which is highly genetically stable over timeAniqa Shahid, Signe MacLennan, Bradley R Jones, et al.
JCI Insight|November 8, 2022
In vivo killing of primary HIV-infected cells by peripheral-injected early memory-enriched anti-HIV duoCAR T cellsKim Anthony-Gonda, Alex Ray, Hang Su, et al.
Nature Communications|January 9, 2021
HIV-1 diversity considerations in the application of the Intact Proviral DNA Assay (IPDA)Natalie N Kinloch, Yanqin Ren, Winiffer D Conce Alberto, et al.
Pageof 6